4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-037618
Options or other derivatives
- Chief Medical Officer acquired 130,000 shares (grant or award)
From the SEC's structured data for this filing
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-037618
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…